Source: siam.pukkato, Shutterstock
To reach millions of people with authentic information on COVID-19 vaccines, Facebook’s (NASDAQ: FB, FB: US) Canada division is partnering with the Canadian government to support the efforts of the health authorities.
The social networking platform will host a question and answer (Q&A) session called 'Your COVID-19 Vaccine Questions Answered' with Dr Theresa Tam, the country's Chief Public Health Officer. It will also rope in Canadian content creators to give them a platform for interacting with their communities about the vaccine.
The Q&A event will take place on March 31. Some of the speakers are Dr Howard Njoo, Deputy Chief Public Health Officer and Dr Evan Adams, who is the Deputy Chief Medical Officer at Indigenous Services Canada. Samantha Yammine, who is a popular science communicator will co-host the event along with Danielle Nadin from the CIHR Institute of Gender and Health.
In a statement, Dr Tam said that the government wants its people to receive authentic and accurate information about vaccines. It wants to work with the content creators to empower them in sending out information to their communities.
Here's what Facebook is doing:
- Apart from hosting the event and partnering with content creators, Facebook will feature content from provincial health organizations on its page named COVID-19 Information Centre.

Source: Pixabay
- Facebook Canada's Global Director, Kevin Chan, stated that ever since the outbreak of the coronavirus pandemic, the company is working to provide authentic information about the virus. Since vaccination roll out, they've given special attention to it.
- The social media giant is also open to new rules that will define what content should be allowed on social networking websites and apps.
- FB claims it weeded out over 2 million pieces of online content that contained misinformation since February. It has also labelled 167 million content pieces related to COVID-19.
A look at the FB’s Stock and Financials
The market cap of Facebook is over US$ 706 billion and offers a 25.42 per cent return on equity. The stocks grew 96 per cent in a year and 9 per cent year-to-date.
The company achieved revenue of US$ 27 billion in Q4 2020, up by 31 per cent year-over-year (YoY). In the same period, the net income rose to US$ 11 billion, 53 per cent up YoY.
The diluted earnings per share (EPS) were at US$ 3.88 in the fourth quarter, up from US$ 2.56 YoY.